(Q35864978)

10 August 2017

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients (English)

1 reference

10 August 2017

0 references

Pseudomonas aeruginosa

0 references

0 references

1 reference

Gerd Döring

1

1 reference

10 August 2017

Christoph Meisner

series ordinal

2

1 reference

10 August 2017

Martin Stern

series ordinal

3

1 reference

10 August 2017

Flagella Vaccine Trial Study Group

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

21 June 2007

1 reference

Proceedings of the National Academy of Sciences of the United States of America

10 August 2017

1 reference

10 August 2017

104

1 reference

10 August 2017

26

1 reference

10 August 2017

11020-11025

1 reference

Pseudomonas aeruginosa Flagella Activate Airway Epithelial Cells through asialoGM1 and Toll-Like Receptor 2 as well as Toll-Like Receptor 5

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

The German cystic fibrosis quality assurance project: clinical features in children and adults

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Pseudomonas aeruginosa adhesins for tracheobronchial mucin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Flagella specific H antigenic schema of Pseudomonas aeruginosa (author's transl)

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Genetic diversity of flagellins of Pseudomonas aeruginosa

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904125

Coming together: the ATS/ERS consensus on clinical pulmonary function testing

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0702403104

Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0702403104

Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations

21 January 2018

1 reference

12 December 2020

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

1 reference

12 December 2020

The First Clinical Trial of Immuno�s Experimental Pseudomonas aeruginosa Flagellar Vaccines

1 reference

12 December 2020

Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0702403104

1 reference

10 August 2017

0 references

1 reference

10 August 2017

PubMed publication ID

17585011

1 reference